Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugsmarket, defines the market attractiveness level of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs industry, describes the types of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market and the development prospects and opportunities of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market in Chapter 13.
By Player:
GlaxoSmithKline
Astellas Pharmaceuticals
Salix Pharmaceuticals Ltd
AstraZenenca
Actavis
Pfizer
By Type:
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Outlook to 2022
-
7.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
-
7.7 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2017-2022)
8 Region and Country-wise Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Analysis and Outlook to 2028
-
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.6 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast (2022-2028)
9 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Preface Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Eluxadoline Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Alosetron Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Rifaximin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Loperamide Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Diphenoxylate + Atropine Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Dicyclomine and Hyoscyamine Consumption and Growth Rate (2017-2022)
-
9.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Preface Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Eluxadoline Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Alosetron Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Rifaximin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Loperamide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Diphenoxylate + Atropine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Dicyclomine and Hyoscyamine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
14.2 Astellas Pharmaceuticals
-
14.2.1 Astellas Pharmaceuticals Company Details
-
14.2.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
14.3 Salix Pharmaceuticals Ltd
-
14.3.1 Salix Pharmaceuticals Ltd Company Details
-
14.3.2 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
14.4 AstraZenenca
-
14.4.1 AstraZenenca Company Details
-
14.4.2 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
14.5 Actavis
-
14.5.1 Actavis Company Details
-
14.5.2 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
-
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Picture
-
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Country (2017-2022)
-
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Preface Consumption and Growth Rate (2017-2022)
-
Figure Global Eluxadoline Consumption and Growth Rate (2017-2022)
-
Figure Global Alosetron Consumption and Growth Rate (2017-2022)
-
Figure Global Rifaximin Consumption and Growth Rate (2017-2022)
-
Figure Global Loperamide Consumption and Growth Rate (2017-2022)
-
Figure Global Diphenoxylate + Atropine Consumption and Growth Rate (2017-2022)
-
Figure Global Dicyclomine and Hyoscyamine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Preface Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Eluxadoline Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alosetron Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rifaximin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Loperamide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diphenoxylate + Atropine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dicyclomine and Hyoscyamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
Table Astellas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
Table Salix Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
Table AstraZenenca (Foundation Year, Company Profile and etc.)
-
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Service
-
